CLUE: CLinical Utility Study of EsoGuard

Completed · Not applicable

Conditions studied: Barrett Esophagus, Barretts Esophagus With Dysplasia, Esophagus Adenocarcinoma

In brief

Utilize real-world data from the commercial use of EsoGuard testing on samples collected with EsoCheck (EC/EG) to evaluate the impact of EsoGuard results on health care provider's decision for endoscopy referral. Assess patient compliance with recommendations for upper endoscopy, and relationship of compliance to positive EsoGuard results.

Key facts

Study ID
NCT06030180
Run by
Lucid Diagnostics, Inc.
People needed
566
Starts
2023-02-23
Expected to finish
2024-12-13
Last updated by the study team
2025-06-27

Who can join

Age: 12 and older, up to 99. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.